Refine by
Cancer Early Articles & Analysis
20 articles found
One of the key issues is drug resistance. Cancer cells often develop resistance to BCL2 inhibitors by upregulating other anti-apoptotic proteins like MCL1 or BCL-XL. ...
These changes can be used to detect cancer early and monitor the effectiveness of treatment. Furthermore, exosomes also carry small RNAs, such as microRNAs, which influence gene expression and can modulate metabolic pathways in recipient cells. ...
They are implicated in a wide range of conditions, from cardiovascular and metabolic disorders to neurological diseases and cancers. By facilitating the early stages of the drug development pipeline, GPCR Screening Services help streamline the identification of lead compounds, optimizing the chances of successful therapeutic outcomes. ...
Traditional approaches often fall short in detecting cancers early or accurately characterizing subtypes necessary for effective treatment. ...
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
The antibody can be released to partially target and attach to HER2 on cancer cells, and upon entering the cancer cells, release chemotherapeutic drugs to kill the cancer cells as well as nearby cells. ...
All three companies are excited to bring such a product into the market with one goal—improving early breast cancer detection. Day 2 Technical training for Datascan engineers continued on the mobile unit. ...
This is an observational cohort study looking at women, 30 years of age or older with a concern or at risk of suspected breast disease or breast cancer. The proposed study aims to examine the diagnostic performance of non-contrast MRI in breast disease by applying quantitative multiparametric MRI ...
For urologists and prostate cancer patients, early detection and treatment are critical to successful outcomes. Approximately 80%- 85% of all prostate cancers are detected in stages I, II or III. Many diagnosed at this stage will likely be disease free after 5 years, with an average 15 year survival rate of 95%.8 A missed diagnosis could be ...
VisionGate’s Non-Intrusive Testing, Patented Cell-CT Imaging and AI-Powered Cancer Detection Work Together to Deliver Early Detection of Lung Cancer. VisionGate’s mission is backed by cutting-edge technology that is designed to save lives through early detection and prevention of lung cancer. ...
Calviri, a company founded by Stephen Johnston, a professor at ASU and the director at the Biodesign Center for Innovations in Medicine, is developing a preventive cancer vaccine in the heart of Phoenix. Startup companies in Phoenix are looking for young professionals who can bring new ideas to the table, to help the industry grow exponentially, Johnston said. ...
ByCalviri
VisionGate, a Breakthrough Liquid-biopsy Technology Company, Leads the Battle Against Lung Cancer through Early Detection Technology with a Simple, Non-Intrusive Sputum Test. ...
This is evident in the countless women who are still misdiagnosed – either receiving a false positive or getting diagnosed in the later stages of the disease. Why Early Detection is Important According to the National Breast Cancer Foundation, if breast cancer is still detected in its early stages (when it is localized ...
The blood test was found to detect colorectal cancer with 92 percent sensitivity and 97 percent specificity. It also was shown to have 89 percent sensitivity and 97 percent specificity detecting early-stage cancer. ...
SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, multi-center observational study in the US for its investigational advanced adenoma (precursor lesions) and colorectal ...
Radiation therapy choices vary for comprehensive breast cancer treatment. One such option, intraoperative radiation therapy (IORT) is employed in many centers around the country. ...
Use of algorithms can help healthcare providers diagnose sepsis early. Throughout our discussion, appropriate algorithms are suggested to help clinicians with diagnosis, risk prediction, prognostics, management of sepsis, and management febrile neutropenia when it develops following cancer therapy. ...
The obtained results revealed that magnetic SiO2-coated Fe3O4 nanoparticles can be a promising candidate for the diagnosis of cervical cancer at an early stage with high accuracy.Keywords: magnetic nanoparticles, diagnostics, uterocervical cancer, E coli, monoclonal antibodies, escherichia coli, cervical cancer, diarrhoea, ...
In addition, we present initial studies with tissue-simulating phantoms that allow the optimum excitation wavelength to be determined for visible-emitting quantum dots used to image surface or near-surface lesions, as found in endoscopic diagnosis of early cancer. We also suggest needed areas for future research for optimisation of quantum dot-based bio-imaging ...
As a non-governmental organization, the American Cancer Society is the largest source of private funds earmarked for cancer research. ...